»Working at Navigo Proteins is fun because of the combined expertise of all my fellow colleagues and their commitment to engineer the best possible molecules to even exceed our partners’ expectations. We employ our scientific creativity to explore innovative approaches and go the extra mile for the optimal solution. With our dedication we aim to contribute to the well-being of patients around the world.«
Uli joined Navigo Proteins in 2011 as CSO. Since 2013 he has had the additional role of a Managing Director. He is responsible for all the technical development of the Precision Capturing and Precision Targeting platforms. Uli has more than 15 years of industry experience in large pharma and biotech companies. At Bayer Healthcare he held the position of Director of Protein Optimization and he spent seven years as Vice President of R&D Biopharmaceuticals at Direvo Biotech. In addition, he worked for at SmithKline Beecham, UK in the New Assay Technology group. Uli gained experience in the field of mass spectrometry and fluorescence correlation spectroscopy during his post-doctoral fellowship at Cornell University, US. He received his PhD in 1996 from the Max-Planck Institute for Biochemistry, Martinsried, Germany.